Ocimum joins Microsoft’s BioIT Alliance
June 28, 2007, Hyderabad – Ocimum Biosolutions, a leading integrated life-sciences solutions provider has joined the BioIT Alliance in the quest to address the growing need for intelligent informatics solutions in the global life-sciences sector.
Subash Lingareddy, President, Ocimum Biosolutions said, “Ocimum is excited to be a part of this global initiative. We look forward to working with other Alliance partners for coming up with cutting edge integrated informatics solutions for enabling quality R&D. This platform further strengthens our goals to come up with affordable solutions for catering diverse economies.”
Don Rule, Platform Strategy Advisor at Microsoft, commented, “We are thrilled to see Ocimum join the BioIT Alliance. As an integrated life-sciences Company, Ocimum brings a unique perspective to this Alliance through their complementing competencies in key technology areas.”
About the BioIT Alliance:
Formed in 2006, the BioIT Alliance is a cross-industry group working to integrate science and technology in order to accelerate the pace of drug discovery and realize the potential of personalized medicine. Founding members include Accelrys Software Inc., Affymetrix, Inc., Agilent Technologies Inc., Amylin Pharmaceuticals, Inc., Applied Biosystems, The BioTeam Inc., Digipede Technologies LLC, Discovery Biosciences Corporation, Geospiza Inc., Hewlett-Packard Development Company, L.P., Illumina Inc., InterKnowlogy, Microsoft Corporation, Sun Microsystems Inc., The Scripps Research Institute, VizX Labs LLC and other key companies in the pharmaceutical, biotech, hardware and software industries. Additional information about the BioIT Alliance can be found on the BioIT Alliance Web site at http://www.bioitalliance.org
About Microsoft:
Founded in 1975, Microsoft (NASDAQ: “MSFT”) is the worldwide leader in software, services and solutions that help people and businesses realize their full potential.
For more information, please visit www.microsoft.com
About Ocimum Biosolutions:
Ocimum Biosolutions is a leading integrated life-sciences R&D enabling company providing focused solutions for enabling different steps of the life-sciences process chain. Ocimum’s strategic presence in USA, Netherlands and India helps offering cutting edge technologies at competitive market rates. The BioMolecules division provides complementary product lines in Microarrays and Oligos using sophisticated proprietary technologies while adhering to strict quality standards. Through Ocichip™ technology, the Company offers one of the widest ranges of catalog arrays and flexible custom arrays with superior probe design. Ocimum offers QUTE™ (Quantitatively Unique Technique Extracted) oligos with stringent quality controls using proprietary purification technology which is in par with HPLC. The Bioresearch division with sophisticated world-class facilities offers a variety of analytical research services in the Molecular Biology space ranging from Sequencing services to gene synthesis. The BioIT division provides flexible end to end solutions for management and analysis of complex biological data. The products and services units within the BioIT division collaborates for providing cutting-edge solutions like complex information and knowledge management, data and literature mining, gene expression, algorithm development, gene identification, multiple-platform software development, database creation and manipulation, and tools for image analysis. The division has 8 products used globally in the LIMS (Biotracker™, Pharmatracker™ and Toxchek™) and Bioinformatics space (Genowiz™, Genchek™, OptGene™ and iRNAchek™).
For more information, please visit: www.ocimumbio.com
